JPMorgan Chase & Co. raised its stake in 111, Inc. (NASDAQ:YI - Free Report) by 43,619.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 306,039 shares of the company's stock after buying an additional 305,339 shares during the period. JPMorgan Chase & Co. owned approximately 3.58% of 111 worth $191,000 at the end of the most recent reporting period.
Separately, Napean Trading & Investment Co Singapore PTE Ltd acquired a new stake in shares of 111 in the fourth quarter valued at approximately $245,000. 21.32% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a "sell (e+)" rating on shares of 111 in a research report on Thursday, April 24th.
Read Our Latest Report on YI
111 Trading Down 0.1 %
Shares of NASDAQ:YI traded down $0.01 on Friday, hitting $7.68. The company had a trading volume of 9,654 shares, compared to its average volume of 33,056. The company has a market cap of $65.68 million, a PE ratio of -1.92 and a beta of 0.47. 111, Inc. has a 52-week low of $4.14 and a 52-week high of $14.10. The business has a 50 day moving average of $8.30 and a 200 day moving average of $7.40.
111 (NASDAQ:YI - Get Free Report) last released its quarterly earnings results on Thursday, March 20th. The company reported ($0.04) earnings per share (EPS) for the quarter. The business had revenue of $527.14 million for the quarter.
111 Profile
(
Free Report)
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
See Also
Before you consider 111, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 111 wasn't on the list.
While 111 currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
